Please assess the completion status of the following clinical trial:

Trial Title: Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ischemic cardiomyopathy, with ischemic myocardial scar~* Sustained monomorphic ventricular tachycardia~* Age \> 18 years~* Prior ICD implantation~Exclusion Criteria:~* VT storm~* NYHA functional class IV~* Additional indication for antiarrhythmic drug therapy~* Contraindication for both study drugs (amiodarone and sotalol).~* Uncontrolled myocardial ischemia.~* LV thrombus.~* Non-ischemic VT substrate.~* Contraindications for anticoagulation.~* Prior substrate ablation in the previous 6 months~* Cr \> 2.5 mg/dL~* Mitral AND aortic mechanical valvular prosthesis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ablation (Type: EXPERIMENTAL): Substrate-based radiofrequency catheter ablation
- Antiarrhythmic drug therapy (Type: ACTIVE_COMPARATOR): Antiarrhythmic drug therapy; amiodarone or sotalol

Based on this trial design, predict the completion outcome and termination type (if applicable).